| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06878664 | Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2… | Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs) | Recruiting |
| NCT05918302 | Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor… | Neuroendocrine Tumors | Recruiting |
| Phase 2 | |||
| NCT06235216 | Sacituzumab govitEcan in THYroid Cancers | Differentiated Thyroid Cancer | Recruiting |
| NCT07061080 | Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab | Advanced Neuroendocrine Carcinomas of The Digestive System | Recruiting |
| Not specified | |||
| NCT03765333 | GETNE Registration of Thyroid Cancer | Thyroid Cancer | Recruiting |